Drug - Integrilin
The trade name of the product as shown on the labeling.

The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Eptifibatide
Multiple ingredients are in alphabetical order.

Strength - 75MG/100ML
The potency of the active ingredient(s), Eptifibatide. May repeat for multiple part products.

Applicant - SCHERING
The firm name holding legal responsibility for Integrilin. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020718
The FDA assigned number to Integrilin. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Integrilin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - May 18, 1998
The date Integrilin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Integrilin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Integrilin is in. Format is RX, OTC, DISCN.

Applicant Full Name - Schering Corp
The full name of the firm holding legal responsibility for the new application of Integrilin.